Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.59 USD | -1.37% | -1.10% | -18.04% |
09/05 | Transcript : Eton Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
09/05 | Eton Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.04% | 9.22Cr | |
+15.41% | 7.82TCr | |
+8.25% | 884.42Cr | |
-12.05% | 507.3Cr | |
+53.66% | 482.42Cr | |
+11.63% | 419.85Cr | |
-23.67% | 227.61Cr | |
+10.30% | 227.99Cr | |
-32.35% | 212Cr | |
+21.04% | 219.67Cr |
- Stock Market
- Equities
- ETON Stock
- News Eton Pharmaceuticals, Inc.
- Eton Pharmaceuticals : B. Riley Resumes Eton Pharmaceuticals at Buy with $10 PT, Sees Potential in 'Robust' Pipeline Despite Regulatory Challenges, Related Delays